636 related articles for article (PubMed ID: 31421135)
1. Effects of TAK-639, a novel topical C-type natriuretic peptide analog, on intraocular pressure and aqueous humor dynamics in mice.
Millar JC; Savinainen A; Josiah S; Pang IH
Exp Eye Res; 2019 Nov; 188():107763. PubMed ID: 31421135
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and intraocular pressure-lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey.
Savinainen A; Prusakiewicz JJ; Oswald J; Spencer E; Lou Z; Cohen ML; Rashidzadeh H; Josiah S
Exp Eye Res; 2019 Dec; 189():107836. PubMed ID: 31626797
[TBL] [Abstract][Full Text] [Related]
3. Nanoencapsulated hybrid compound SA-2 with long-lasting intraocular pressure-lowering activity in rodent eyes.
Stankowska DL; Millar JC; Kodati B; Behera S; Chaphalkar RM; Nguyen T; Nguyen KT; Krishnamoorthy RR; Ellis DZ; Acharya S
Mol Vis; 2021; 27():37-49. PubMed ID: 33633438
[TBL] [Abstract][Full Text] [Related]
4. Netarsudil Improves Trabecular Outflow Facility in Patients with Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 2 Study.
Sit AJ; Gupta D; Kazemi A; McKee H; Challa P; Liu KC; Lopez J; Kopczynski C; Heah T
Am J Ophthalmol; 2021 Jun; 226():262-269. PubMed ID: 33524367
[TBL] [Abstract][Full Text] [Related]
5. ID1 and ID3 are Negative Regulators of TGFβ2-Induced Ocular Hypertension and Compromised Aqueous Humor Outflow Facility in Mice.
Mody AA; Millar JC; Clark AF
Invest Ophthalmol Vis Sci; 2021 May; 62(6):3. PubMed ID: 33938911
[TBL] [Abstract][Full Text] [Related]
6. Presence of functional type B natriuretic peptide receptor in human ocular cells.
Pang IH; Shade DL; Matsumoto S; Steely HT; DeSantis L
Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1724-31. PubMed ID: 8759339
[TBL] [Abstract][Full Text] [Related]
7. Effect of Cromakalim Prodrug 1 (CKLP1) on Aqueous Humor Dynamics and Feasibility of Combination Therapy With Existing Ocular Hypotensive Agents.
Roy Chowdhury U; Rinkoski TA; Bahler CK; Millar JC; Bertrand JA; Holman BH; Sherwood JM; Overby DR; Stoltz KL; Dosa PI; Fautsch MP
Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5731-5742. PubMed ID: 29114841
[TBL] [Abstract][Full Text] [Related]
8. Ocular hypotension induced by intravitreally injected C-type natriuretic peptide.
Takashima Y; Taniguchi T; Yoshida M; Haque MS; Igaki T; Itoh H; Nakao K; Honda Y; Yoshimura N
Exp Eye Res; 1998 Jan; 66(1):89-96. PubMed ID: 9533834
[TBL] [Abstract][Full Text] [Related]
9. Assessment of aqueous humor dynamics in the mouse by a novel method of constant-flow infusion.
Millar JC; Clark AF; Pang IH
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):685-94. PubMed ID: 20861483
[TBL] [Abstract][Full Text] [Related]
10. CNP-induced changes in pHi, cGMP/cAMP and mRNA expression of natriuretic peptide receptors in human trabecular meshwork cells.
Zhong L; Chu E; Chu J; Chu TC
J Ocul Pharmacol Ther; 2003 Oct; 19(5):425-36. PubMed ID: 14583135
[TBL] [Abstract][Full Text] [Related]
11. Ocular hypotensive mechanism of intravitreally injected brain natriuretic peptide in rabbit.
Takashima Y; Taniguchi T; Yoshida M; Haque MS; Yoshimura N; Honda Y
Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2671-7. PubMed ID: 8977481
[TBL] [Abstract][Full Text] [Related]
12. NCX 667, a Novel Nitric Oxide Donor, Lowers Intraocular Pressure in Rabbits, Dogs, and Non-Human Primates and Enhances TGFβ2-Induced Outflow in HTM/HSC Constructs.
Bastia E; Toris CB; Brambilla S; Galli C; Almirante N; Bergamini MVW; Masini E; Sgambellone S; Unser AM; Ahmed F; Torrejon KY; Navratil T; Impagnatiello F
Invest Ophthalmol Vis Sci; 2021 Mar; 62(3):17. PubMed ID: 33704360
[TBL] [Abstract][Full Text] [Related]
13. Adenoviral gene transfer of active human transforming growth factor-{beta}2 elevates intraocular pressure and reduces outflow facility in rodent eyes.
Shepard AR; Millar JC; Pang IH; Jacobson N; Wang WH; Clark AF
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2067-76. PubMed ID: 19959644
[TBL] [Abstract][Full Text] [Related]
14. Effects of dinucleoside polyphosphates on trabecular meshwork cells and aqueous humor outflow facility.
Soto D; Pintor J; Peral A; Gual A; Gasull X
J Pharmacol Exp Ther; 2005 Sep; 314(3):1042-51. PubMed ID: 15947035
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Aqueous Humor Dynamics in the Rodent by Constant Flow Infusion.
Millar JC; Phan TN; Pang IH
Methods Mol Biol; 2018; 1695():109-120. PubMed ID: 29190023
[TBL] [Abstract][Full Text] [Related]
16. Effect of 8-iso prostaglandin E2 on aqueous humor dynamics in monkeys.
Wang RF; Lee PY; Mittag TW; Podos SM; Serle JB; Becker B
Arch Ophthalmol; 1998 Sep; 116(9):1213-6. PubMed ID: 9747682
[TBL] [Abstract][Full Text] [Related]
17. The effect of topical CS-088, an angiotensin AT1 receptor antagonist, on intraocular pressure and aqueous humor dynamics in rabbits.
Inoue T; Yokoyoma T; Mori Y; Sasaki Y; Hosokawa T; Yanagisawa H; Koike H
Curr Eye Res; 2001 Aug; 23(2):133-8. PubMed ID: 11840352
[TBL] [Abstract][Full Text] [Related]
18. Effects of platelet-derived growth factor on aqueous humor dynamics.
Syriani E; Cuesto G; Abad E; Pelaez T; Gual A; Pintor J; Morales M; Gasull X
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3833-9. PubMed ID: 19357356
[TBL] [Abstract][Full Text] [Related]
19. Aqueous humor dynamics in monkeys after topical 8-iso PGE(2).
Gabelt BT; Seeman JL; Podos SM; Mittag TW; Kaufman PL
Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):892-9. PubMed ID: 14985307
[TBL] [Abstract][Full Text] [Related]
20. sCD44 overexpression increases intraocular pressure and aqueous outflow resistance.
Giovingo M; Nolan M; McCarty R; Pang IH; Clark AF; Beverley RM; Schwartz S; Stamer WD; Walker L; Grybauskas A; Skuran K; Kuprys PV; Yue BY; Knepper PA
Mol Vis; 2013; 19():2151-64. PubMed ID: 24194636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
